Remove Documentation Remove FDA Remove Labelling Remove Pharmaceutical Companies
article thumbnail

Does Blue Cross Blue Shield cover Ozempic?

The Checkup by Singlecare

Health condition Insurance companies are much more likely to cover Ozempic when it’s prescribed for diabetes than for weight loss. That’s because the Food and Drug Administration (FDA) has approved it for Type 2 diabetes , while weight management is technically an off-label treatment.

article thumbnail

What are patient assistance programs?

The Checkup by Singlecare

Eligible patients will be required to provide documentation of financial and insurance information to show they have no means of obtaining the medication without assistance. Additionally, the drug must be FDA-approved for the condition being treated (i.e., not being used off-label).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pharmacovigilance deep dive: risk minimisation measures

European Pharmaceutical Review

The sampling strategy must be supported by sound and properly cited sources whose conclusions must be presented as supportive elements in the study documents. The following four elements of sampling methodology were found to be under-documented in RMM effectiveness studies: Supporting documentation for country/region selection.

article thumbnail

External control arms and debunking real-world data myths

pharmaphorum

ECAs are being used to support the primary approval, label expansion of their assets and even go/no-go decisions for trials. The industry has looked to regulators for guidance, and the Food and Drug Administration (FDA) has been quick to respond. Myth 2: Implementing an ECA requires too much money, time and resource.

FDA 89
article thumbnail

Complete guide on pharmaceutical medical affairs

Viseven

They provide information about the following: Off-label usage Publications Safety information Independent medical education. Under its internal affairs, the pharmaceutical ones bring together the research and commercial wings of the pharma businesses. The role of medical affairs in pharmaceutical companies.